Literature DB >> 2357234

Regional distribution and molecular forms of rat islet amyloid polypeptide.

J Asai1, M Nakazato, M Miyazato, K Kangawa, H Matsuo, S Matsukura.   

Abstract

Using a highly sensitive and specific radioimmunoassay (RIA) for rat islet amyloid polypeptide (IAPP), we clarified regional distribution and molecular forms of rat IAPP. IAPP[1-37] and IAPP[19-37] were identified in normal rat pancreas by sequence analyses IAPP[19-37], accounting for 57% of IAPP-immunoreactivity in rat pancreas, is a major molecular form of rat IAPP moiety. In human, however, IAPP[1-37] is the major component, with IAPP[17-37] composing as little as 2-6% of IAPP-immunoreactivity in pancreas. This indicates that processing of IAPP in pancreas differs in species. A large amount of IAPP (328.5 +/- 25.0 pmol/g wet weight) was found in rat pancreas and the peptide was also detected in pyloric antrum of the stomach, duodenum, jejunum, ileum, and colon at 0.1-0.8% of the level of pancreas. It was not detected in central nervous system. The content of rat IAPP in pancreas fell to 54% of control after 4 day fasting. The distribution of IAPP suggests its possible endocrine or paracrine function in pancreas and gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357234     DOI: 10.1016/0006-291x(90)90400-h

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

2.  Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat.

Authors:  G Clementi; A Caruso; V M Cutuli; E de Bernardis; A Prato; M Amico-Roxas
Journal:  Experientia       Date:  1996-07-15

3.  Islet amyloid polypeptide in insulinoma and in the islets of the pancreas of non-diabetic and diabetic subjects.

Authors:  H Toshimori; R Narita; M Nakazato; J Asai; T Mitsukawa; K Kangawa; H Matsuo; K Takahashi; S Matsukura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 4.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

5.  Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Eriksson; M Nakazato; M Miyazato; K Shiomi; S Matsukura; L Groop
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

6.  Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

Authors:  S Doré; S Kar; R Quirion
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis.

Authors:  L Christmanson; C Betsholtz; A Leckström; U Engström; C Cortie; K H Johnson; T E Adrian; P Westermark
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

8.  Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study.

Authors:  H Mulder; A C Lindh; F Sundler
Journal:  Cell Tissue Res       Date:  1993-12       Impact factor: 5.249

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.